European Biotech Acquisition Corp. Units
EBACU
EBACU was delisted on the 2nd of March, 2023.
0 hedge funds and large institutions have $0 invested in European Biotech Acquisition Corp. Units in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 11 closing their positions.
100% less funds holding
Funds holding: 11 → 0 (-11)
100% less capital invested
Capital invested by funds: $8M → $0 (-$8M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 11
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$2.01M |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$1.78M |
| 3 |
Jane Street
New York
|
-$1.47M |
| 4 |
HF
HRT Financial
New York
|
-$755K |
| 5 |
Walleye Capital
New York
|
-$733K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Millennium Management
New York
| – | -$2.01M | -200,000 | Closed |
|
|
2
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$1.78M | -176,274 | Closed |
|
|
3
Jane Street
New York
| – | -$1.47M | -146,340 | Closed |
|
|
HF
4
HRT Financial
New York
| – | -$755K | -74,907 | Closed |
|
|
5
Walleye Capital
New York
| – | -$733K | -72,784 | Closed |
|
6
Walleye Trading
New York
| – | -$504K | -50,000 | Closed |
|
|
CSS
7
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$346K | -34,367 | Closed |
|
|
LCM
8
Landscape Capital Management
Englewood,
New Jersey
| – | -$307K | -30,463 | Closed |
|
|
CS
9
Clear Street
New York
| – | -$77K | -7,598 | Closed |
|
|
TAM
10
Terrapin Asset Management
Miami,
Florida
| – | -$6.04K | -600 | Closed |
|
|
DCM
11
Dupont Capital Management
Wilmington,
Delaware
| – | -$42 | -4 | Closed |
|
EBACU Hedge Fund Activity: Q1 2023 in Review
0 of the 6,277 institutional investors tracked by Wall St. Rank reported a position in European Biotech Acquisition Corp. Units (EBACU) for Q1 2023, worth a combined $0 — down 100% from $8M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of EBACU and 0 opened new positions — a net loss of 11 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Millennium Management, exiting entirely with an estimated $2.01M sold.
- 0 institutional investors held European Biotech Acquisition Corp. Units (EBACU) as of Q1 2023, down from 11 in Q4 2022.
- Funds reported $0 of European Biotech Acquisition Corp. Units stock for Q1 2023, down 100% quarter-over-quarter.
- 0 funds opened new European Biotech Acquisition Corp. Units positions in Q1 2023 and 11 closed out, a net change of -11 holders.
- The largest European Biotech Acquisition Corp. Units seller in Q1 2023 was Millennium Management, an estimated $2.01M sold.
Based on aggregated 13F filings for Q1 2023.